Sreedevi Ramakrishnaiah, MD
Internal Medicine · South Charleston, WVNPI 1518215698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 35.9% of the total.
Across 40 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$273
- Novartis$124
- Pfizer$104
- Johnson & Johnson$101
- Shionogi Inc$89
- Baxter Healthcare$26
- plus $42 from 2 others
What the payments were for
- Food & beverage$759100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 16 | $273 |
| Novartis | 6 | $124 |
| Pfizer | 5 | $104 |
| Johnson & Johnson | 7 | $101 |
| Shionogi Inc | 3 | $89 |
| Baxter Healthcare | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Smith+Nephew | 1 | $17 |
How this compares
$759 in reported general payments places this provider in the 65th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 21 | $165 |
| Cefdinir | 16 | $156 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $140 |
| Metoprolol Succinate | 16 | $94 |
| Prednisone | 29 | $70 |
| Ciprofloxacin Hcl | 19 | $54 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $42 |
| Furosemide | 18 | $40 |
| ClopidogrelClopidogrel Bisulfate | 13 | $35 |
| Amlodipine Besylate | 15 | $31 |
| Metoprolol Tartrate | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in South Charleston
- Dina CrinitiSouth Charleston$12K
- Franklin MooreSouth Charleston$8K
- William ChapmanCharleston$1.7M
- David PickeringParkersburg$599K
- Govind PatelFairmont$59K
- Bisher MustafaHuntington$28K
- Johny AlencherryMartinsburg$27K
- Ali KhanBuckhannon$21K
- Joseph HashemBerkeley Springs$21K
- David PatickHuntington$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.